Learn more

IBFB GMBH PRIVATES INST FUER B

Overview
  • Total Patents
    15
About

IBFB GMBH PRIVATES INST FUER B has a total of 15 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Germany, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are EHBBVI INK, SHANGHAI HENGRUI PHARM CO LTD and AN2H DISCOVERY LTD.

Patent filings in countries

World map showing IBFB GMBH PRIVATES INST FUER Bs patent filings in countries

Patent filings per year

Chart showing IBFB GMBH PRIVATES INST FUER Bs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Arkona Christoph 8
#2 Heinicke Jochen 6
#3 Klausmeier Uwe 6
#4 Herrmann Konrad 4
#5 Leistner Siegfried 4
#6 Hermann Konrad 4
#7 Wippich Petra 2
#8 Saalbach Anja 2
#9 Hausmann Elda H S 1

Latest patents

Publication Filing date Title
EP1357114A1 Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP)
DE10113604A1 Process for the cleavage of the human growth hormone GH
DE10104895A1 Use of 3-(2-mercaptoethyl)-1-methyl-quinazoline-2,4(1H,3H)-dione as human phosphodiesterase inhibitor, as tumor cell differentiation modulator and cell culture growth stimulant
DE10101324C1 New 1-(dimercaptoalkyl)-quinazoline-2,4(1H,3H)-diones, are stable matrix metalloproteinase inhibitors useful e.g. for treating rheumatism, tumor metastasis or sunburn
DE10046728C1 New mercaptomethyl-substituted tricyclic quinazolinone derivatives, are matrix metalloprotease inhibitors useful for treating cancer, rheumatism, inflammatory reactions or allergies
DE10006904C1 New mesenchymal stem cell antigen, for producing monoclonal antibodies for e.g. bone marrow typing, tumor diagnosis, or recovering autologous stem cells from whole blood for treating non-healing wounds
DE10018036A1 Determining optimal hybridization parameters for nucleic acid, useful for detecting immunoregulatory genes, comprises depositing control and test RNA on same membrane
DE19940494C1 New fused 1- or 3-(mercaptoalkyl)-pyrimidine-2,4(1H, 3H)-dione derivatives, as stable collagenase inhibitors useful e.g. for treating rheumatism, tumor metastasis or sunburn
DE19927306A1 New mesenchymal stem cell antigen, used to raise antibodies for e.g. cell characterization and bone marrow typing